Gene expression profile in fibroblasts of Huntington's disease patients and controls

Journal of the Neurological Sciences

Volumn 337, Issue 1-2, 2014, Pages 42-46

  Marchina, Eleonora ^a   Misasi, Silvia ^a   Bozzato, Andrea ^a   Ferraboli, Sergio ^a   Agosti, Chiara ^a   Rozzini, Luca ^a   Borsani, Giuseppe ^a   Barlati, Sergio ^a   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Biomarkers; Gene expression profile; Human fibroblasts; Huntingtin; Huntington's disease; Neurodegeneration; PolyQ

Indexed keywords

BIOMARKERS; GENE EXPRESSION PROFILE; HUMAN FIBROBLASTS; HUNTINGTIN; HUNTINGTON'S DISEASE; NEURODEGENERATION; POLYQ;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; FEMALE; FIBROBLASTS; HUMANS; HUNTINGTON DISEASE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NERVE TISSUE PROTEINS; PHOSPHOLIPASE C BETA; REPRODUCIBILITY OF RESULTS; RHO-ASSOCIATED KINASES; TRANSCRIPTOME; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84894080255     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.11.014     Document Type: Article

References (57)

1. O. Quarrell, K.L. O'Donovan, O. Bandmann, and M. Strong The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-analysis PLoS Curr 4 2012 [e4f8606b742ef3]
2. J.F. Gusella, N.S. Wexler, P.M. Conneally, S.L. Naylor, M.A. Anderson, and R.E. Tanzi et al. A polymorphic DNA marker genetically linked to Huntington's disease Nature 306 5940 1983 234 238
3. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group Cell 72 6 1993 971 983
4. C.A. Ross When more is less: pathogenesis of glutamine repeat neurodegenerative diseases Neuron 15 3 1995 493 496
5. J.B. Penney Jr., J.P. Vonsattel, M.E. MacDonald, J.F. Gusella, and R.H. Myers CAG repeat number governs the development rate of pathology in Huntington's disease Ann Neurol 41 5 1997 689 692
6. G.P. Bates History of genetic disease: the molecular genetics of Huntington disease - a history Nat Rev Genet 6 10 2005 766 773
7. A. Semaka, S. Creighton, S. Warby, and M.R. Hayden Predictive testing for Huntington disease: interpretation and significance of intermediate alleles Clin Genet 70 4 2006 283 294
8. D.C. Rubinsztein, J. Leggo, R. Coles, E. Almqvist, V. Biancalana, and J.J. Cassiman et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats Am J Hum Genet 59 1 1996 16 22
9. N.G. Ranen, O.C. Stine, M.H. Abbott, M. Sherr, A.M. Codori, and M.L. Franz et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease Am J Hum Genet 57 3 1995 593 602
10. M. Duyao, C. Ambrose, R. Myers, A. Novelletto, F. Persichetti, and M. Frontali et al. Trinucleotide repeat length instability and age of onset in Huntington's disease Nat Genet 4 4 1993 387 392
11. A. Hodges, A.D. Strand, A.K. Aragaki, A. Kuhn, T. Sengstag, and G. Hughes et al. Regional and cellular gene expression changes in human Huntington's disease brain Hum Mol Genet 15 6 2006 965 977
12. J. Sassone, C. Colciago, G. Cislaghi, V. Silani, and A. Ciammola Huntington's disease: the current state of research with peripheral tissues Exp Neurol 219 2 2009 385 397
13. J.H. Cha Transcriptional signatures in Huntington's disease Prog Neurobiol 83 4 2007 228 248
14. A. Dalrymple, E.J. Wild, R. Joubert, K. Sathasivam, M. Bjorkqvist, and A. Petersen et al. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates J Proteome Res 6 7 2007 2833 2840
15. A.N. Anderson, F. Roncaroli, A. Hodges, M. Deprez, and F.E. Turkheimer Chromosomal profiles of gene expression in Huntington's disease Brain 131 Pt 2 2008 381 388
16. K.H. Chang, Y.C. Chen, Y.R. Wu, W.F. Lee, and C.M. Chen Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients PLoS One 7 9 2012 e46492
17. J. Krzyszton-Russjan, D. Zielonka, J. Jackiewicz, S. Kusmirek, I. Bubko, and A. Klimberg et al. A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers J Bioenerg Biomembr 45 1-2 2013 71 85
18. M.A. Pouladi, Y. Xie, N.H. Skotte, D.E. Ehrnhoefer, R.K. Graham, and J.E. Kim et al. Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression Hum Mol Genet 19 8 2010 1528 1538
19. P. del Hoyo, A. Garcia-Redondo, F. de Bustos, J.A. Molina, Y. Sayed, and H. Alonso-Navarro et al. Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease Neurochem Res 31 9 2006 1103 1109
20. J.L. Mazzola, and M.A. Sirover Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts J Neurochem 76 2 2001 442 449
21. H. Seo, K.C. Sonntag, and O. Isacson Generalized brain and skin proteasome inhibition in Huntington's disease Ann Neurol 56 3 2004 319 328
22. R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, and S. Dudoit et al. Bioconductor: open software development for computational biology and bioinformatics Genome Biol 5 10 2004 R80
23. Z. Wu, and R.A. Irizarry Stochastic models inspired by hybridization theory for short oligonucleotide arrays J Comput Biol 12 6 2005 882 893
24. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 [Article3]
25. P.H. Westfall, and S.S. Young Resampling-based multiple testing: examples and methods for p-value adjustment 1993 Wiley New York; Chichester
26. S. Draghici, P. Khatri, P. Bhavsar, A. Shah, S.A. Krawetz, and M.A. Tainsky Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate Nucleic Acids Res 31 13 2003 3775 3781
27. S.E. Andrew, Y.P. Goldberg, J. Theilmann, J. Zeisler, and M.R. Hayden A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing Hum Mol Genet 3 1 1994 65 67
28. T. Ashizawa, J.R. Dubel, and Y. Harati Somatic instability of CTG repeat in myotonic dystrophy Neurology 43 12 1993 2674 2678
29. M. Swami, A.E. Hendricks, T. Gillis, T. Massood, J. Mysore, and R.H. Myers et al. Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset Hum Mol Genet 18 16 2009 3039 3047
30. J. Branco, I. Al-Ramahi, L. Ukani, A.M. Perez, P. Fernandez-Funez, and D. Rincon-Limas et al. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases Hum Mol Genet 17 3 2008 376 390
31. P.O. Bauer, H.K. Wong, F. Oyama, A. Goswami, M. Okuno, and Y. Kino et al. Inhibition of Rho kinases enhances the degradation of mutant huntingtin J Biol Chem 284 19 2009 13153 13164
32. J.M. Oliveira, and R.N. Lightowlers Could successful (mitochondrial) networking help prevent Huntington's disease? EMBO Mol Med 2 12 2010 487 489
33. L.S. Kaltenbach, E. Romero, R.R. Becklin, R. Chettier, R. Bell, and A. Phansalkar et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration PLoS Genet 3 5 2007 e82
34. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 9 2001 e45
35. F.O. Walker Huntington's disease Lancet 369 9557 2007 218 228
36. J.M. van der Burg, M. Bjorkqvist, and P. Brundin Beyond the brain: widespread pathology in Huntington's disease Lancet Neurol 8 8 2009 765 774
37. P.A. Oude Weernink, L. Han, K.H. Jakobs, and M. Schmidt Dynamic phospholipid signaling by G protein-coupled receptors Biochim Biophys Acta 1768 4 2007 888 900
38. V.R. Lo Vasco, M. Leopizzi, C. Chiappetta, C. Puggioni, C. Di Cristofano, and C. Della Rocca Expression of phosphoinositide-specific phospholipase C enzymes in human skin fibroblasts Connect Tissue Res 54 1 2013 1 4
39. M.J. Rebecchi, and S.N. Pentyala Structure, function, and control of phosphoinositide-specific phospholipase C Physiol Rev 80 4 2000 1291 1335
40. I. Bezprozvanny Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington's disease Subcell Biochem 45 2007 323 335
41. H. Zhang, S. Das, Q.Z. Li, I. Dragatsis, J. Repa, and S. Zeitlin et al. Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts BMC Neurosci 9 2008 38
42. T.S. Tang, H. Tu, E.Y. Chan, A. Maximov, Z. Wang, and C.L. Wellington et al. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1 Neuron 39 2 2003 227 239
43. F. Squitieri, A. Falleni, M. Cannella, S. Orobello, F. Fulceri, and P. Lenzi et al. Abnormal morphology of peripheral cell tissues from patients with Huntington disease J Neural Transm 117 1 2010 77 83
44. C.M. Pickart Mechanisms underlying ubiquitination Annu Rev Biochem 70 2001 503 533
45. Y. Ye, and M. Rape Building ubiquitin chains: E2 enzymes at work Nat Rev Mol Cell Biol 10 11 2009 755 764
46. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol Rev 82 2 2002 373 428
47. A. Ciechanover Proteolysis: from the lysosome to ubiquitin and the proteasome Nat Rev Mol Cell Biol 6 1 2005 79 87
48. H. Gonen, B. Bercovich, A. Orian, A. Carrano, C. Takizawa, and K. Yamanaka et al. Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha J Biol Chem 274 21 1999 14823 14830
49. A. Khoshnan, J. Ko, E.E. Watkin, L.A. Paige, P.H. Reinhart, and P.H. Patterson Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity J Neurosci 24 37 2004 7999 8008
50. K. Riento, and A.J. Ridley Rocks: multifunctional kinases in cell behaviour Nat Rev Mol Cell Biol 4 6 2003 446 456
51. S.K. Pollitt, J. Pallos, J. Shao, U.A. Desai, A.A. Ma, and L.M. Thompson et al. A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor Neuron 40 4 2003 685 694
52. P.O. Bauer, R. Hudec, A. Goswami, M. Kurosawa, G. Matsumoto, and K. Mikoshiba et al. ROCK-phosphorylated vimentin modifies mutant huntingtin aggregation via sequestration of IRBIT Mol Neurodegener 7 2012 43
53. R. Fodde, R. Smits, and H. Clevers APC, signal transduction and genetic instability in colorectal cancer Nat Rev Cancer 1 1 2001 55 67
54. Y. Fu, S. Zheng, N. An, T. Athanasopoulos, L. Popplewell, and A. Liang et al. Beta-catenin as a potential key target for tumor suppression Int J Cancer 129 7 2011 1541 1551
55. B.T. MacDonald, K. Tamai, and X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev Cell 17 1 2009 9 26
56. R.K. Kalathur, M.A. Hernandez-Prieto, and M.E. Futschik Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database BMC Neurol 12 2012 47
57. J.D. Godin, G. Poizat, M.A. Hickey, F. Maschat, and S. Humbert Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease EMBO J 29 14 2010 2433 2445